Twist Bioscience Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Twist Bioscience Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3447
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Twist Bioscience Corp (Twist Bioscience) is a DNA specializing and development company that develops DNA products ad DNA synthesis process. The company provides products includes DNA pools for gRNA cloning such as unamplified oligo pools, cloning-ready oligo pools; protein scanning single variant libraries, clonal perfect genes and non-clonal fragments, among others. The company operates in the US, Europe, Israel, and Singapore. Twist Bioscience is headquartered in San Francisco, California, the US.

Twist Bioscience Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Twist Bioscience Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Twist Bioscience Corp, Medical Devices Deals, 2012 to YTD 2018 9
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Twist Bioscience Raises Additional USD27 Million in Venture Financing 12
Twist Bioscience Raises USD33 Million in Venture Financing 14
Twist Bioscience Raises USD2.6 Million Financing 15
Twist Bioscience Raises USD61 Million in Series D Venture Financing 16
Twist Bioscience Raises USD37 Million in Series C Venture Financing 18
Twist Bioscience Raises USD26 Million in Series B Financing 20
Twist Bioscience Secures USD9.11 Million in Series A Funding 21
Twist Bioscience Raises US$4.7 Million In Series A Financing 22
Partnerships 23
Twist Bioscience and Desktop Genetics Enter into Partnership 23
Genome Compiler Enters into Integration Agreement with Addgene 24
Genome Compiler Enters into Co-Development Agreement with De Novo DNA 25
Equity Offering 26
Twist Bioscience Raises USD50 Million in Private Placement of Shares 26
Twist Bioscience Corp – Key Competitors 27
Twist Bioscience Corp – Key Employees 28
Twist Bioscience Corp – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Strategy And Business Planning 30
Feb 28, 2018: Twist Bioscience Expands North American Presence With Office in San Diego, California 30
Corporate Communications 31
Jun 20, 2018: Twist Bioscience Appoints Jim Thorburn CFO And Aaron Sato As CSO Of Pharma 31
Government and Public Interest 32
Jul 17, 2017: Sphere Fluidics and Partners Win Major InnovateUK Grant to Develop the World’s First Desktop Genome Editing System 32
Product News 33
Jun 18, 2018: Twist Bioscience Expands Human Core Exome and Custom Next-Generation Sequencing Solutions with High Throughput Offering 33
Feb 14, 2018: Twist Bioscience Launches Exome and Custom Target Enrichment Solutions for Genomics and Clinical Researchers Conducting Next-Generation Sequencing 34
Other Significant Developments 35
Jul 11, 2017: Quintara Biosciences Partners with Twist Bioscience to Launch New Gene Fragment and Cloning Services, qBlocks and qGenes 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Key Facts 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Twist Bioscience Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Twist Bioscience Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Twist Bioscience Corp, Medical Devices Deals, 2012 to YTD 2018 9
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Twist Bioscience Raises Additional USD27 Million in Venture Financing 12
Twist Bioscience Raises USD33 Million in Venture Financing 14
Twist Bioscience Raises USD2.6 Million Financing 15
Twist Bioscience Raises USD61 Million in Series D Venture Financing 16
Twist Bioscience Raises USD37 Million in Series C Venture Financing 18
Twist Bioscience Raises USD26 Million in Series B Financing 20
Twist Bioscience Secures USD9.11 Million in Series A Funding 21
Twist Bioscience Raises US$4.7 Million In Series A Financing 22
Twist Bioscience and Desktop Genetics Enter into Partnership 23
Genome Compiler Enters into Integration Agreement with Addgene 24
Genome Compiler Enters into Co-Development Agreement with De Novo DNA 25
Twist Bioscience Raises USD50 Million in Private Placement of Shares 26
Twist Bioscience Corp, Key Competitors 27
Twist Bioscience Corp, Key Employees 28
Twist Bioscience Corp, Subsidiaries 29

List of Figures
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Twist Bioscience Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Twist Bioscience Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • UTC Engenharia SA:企業の戦略的SWOT分析
    UTC Engenharia SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • DMC Global Inc (BOOM):企業の財務・戦略的SWOT分析
    Summary DMC Global Inc (DMC), formerly Dynamic Materials Corp is an industrial equipment and machinery company that manufactures, distributes, and markets explosion welded clad metal plates. The company’s products include oilfield products, explosive metalworking equipment, and AMK welding equipment …
  • BioNTech AG-製薬・医療分野:企業M&A・提携分析
    Summary BioNTech AG (BioNTech) is a biotech company that develops biomarker based diagnostics. The company’s products include RNXtract and mammatyper, and cell and gene therapies. It pipeline products include BioNTech mRNA pharmaceuticals, BioNTech cell and gene, and BioNTech protein therapeutics. B …
  • WebMD Health Corp:企業の戦略的SWOT分析
    WebMD Health Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Singapore Telecommunications Ltd:企業の戦略・SWOT・財務分析
    Singapore Telecommunications Ltd - Strategy, SWOT and Corporate Finance Report Summary Singapore Telecommunications Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Edison International (EIX):企業の財務・戦略的SWOT分析
    Edison International (EIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Greif Inc (GEF):企業の財務・戦略的SWOT分析
    Greif Inc (GEF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • ConforMIS Inc (CFMS):企業の財務・戦略的SWOT分析
    Summary ConforMIS Inc (ConforMIS) is a medical technology company that manufactures, develops, and markets joint replacement implants. The company’s knee replacement implant products include iTotal CR a cruciate-retaining product, iTotal PS a posterior cruciate ligament substituting product, and iDu …
  • Church & Dwight Co Inc:戦略・SWOT・企業財務分析
    Church & Dwight Co Inc - Strategy, SWOT and Corporate Finance Report Summary Church & Dwight Co Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • LivaNova PLC (LIVN)-医療機器分野:企業M&A・提携分析
    Summary LivaNova PLC (LivaNova) is a medical technology company that offers medical devices for cardiac surgery, neuromodulation and cardiac rhythm management. The company’s neuromodulation segment provides vagus nerve stimulation therapy system, an implantable device for the people affected by trea …
  • Valero Energy Corporation:企業の戦略・SWOT・財務情報
    Valero Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Valero Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Unified Grocers, Inc.:戦略・SWOT・企業財務分析
    Unified Grocers, Inc. - Strategy, SWOT and Corporate Finance Report Summary Unified Grocers, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • OriGene Technologies Inc-製薬・医療分野:企業M&A・提携分析
    Summary OriGene Technologies Inc (OriGene) is a research tool company that develops cDNA. The company creates commercial collection of full-length human cDNAs in expression vector. It develops, manufactures and sells genome research and diagnostic products. OriGene’s products include qPCR reagents, …
  • Diversicare Healthcare Services Inc (DVCR):製薬・医療:M&Aディール及び事業提携情報
    Summary Diversicare Healthcare Services Inc (Diversicare), formerly Advocat Inc is a healthcare service provider that offers post acute care services and short term rehabilitation and long-term care services to nursing home patients. The company’s services include life steps rehabilitation program, …
  • Euskaltel SA (EKT):企業の財務・戦略的SWOT分析
    Euskaltel SA (EKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Ameriprise Financial, Inc.:企業の戦略・SWOT・財務分析
    Ameriprise Financial, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ameriprise Financial, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Alesi Surgical Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Alesi Surgical Ltd (Alesi Surgical), formerly Asalus Medical Instruments Ltd, is a medical device company that develops and markets laparoscopic surgical smoke handling systems. The company offers Ultravision, a system that removes laparoscopic surgical smoke without the need for gas exchang …
  • Celldex Therapeutics Inc (CLDX):製薬・医療:M&Aディール及び事業提携情報
    Summary Celldex Therapeutics Inc (Celldex) is a bio-pharmaceutical company that discovers, develops and commercializes targeted immunotherapy technologies and cancer-targeting biologicsfor the treatment of various types of cancers. The company’s developmental pipeline comprises therapeutic antibodie …
  • Iamgold Corporation:企業のM&A・事業提携・投資動向
    Iamgold Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Iamgold Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Reliance Steel & Aluminum Co:企業の戦略・SWOT・財務分析
    Reliance Steel & Aluminum Co - Strategy, SWOT and Corporate Finance Report Summary Reliance Steel & Aluminum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆